Senova Technology Company Limited sell "Cagrilintide"
Basic Information
277
14
6
3.8(12)
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
Cagrilintide
Details
Substance
Manufacturer(s)
Specifications
- Indication: Management of type 2 diabetes and related metabolic/weight conditions
- IUPAC Name: 20-[[(1S)-4-[[(2S)-6-amino-1-[[(4R,7S,10S,13S,16S,19R)-4-[[(2S)-1-[[(2S,3R)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2R)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-4-amino-1-[[(2S)-1-[[2-[(2S)-2-[[(2S,3S)-1-[[(
- EC Number: 974-120-5
- Molecular Weight: 4409
- Chemical Formula: C194H312N54O59S2
- CAS Number: 1415456-99-3
- Strength: Strength as specified by the manufacturer; refer to product labelling for the exact dosage
- Storage Conditions: Store in a tightly closed original container in a cool, dry place (15-25°C), protected from light and moisture
- Shelf Life: 24 months from date of manufacture when stored under the labelled conditions, unopened
- Regulatory Approval Status: Registered/marketed medicine in its country(ies) of sale; specific regulatory status and approvals vary by market
- Packaging: Packaged in tamper-evident primary packaging (blister, bottle, tube, vial, or sachet as applicable) with a printed leaflet/label
Other Information
Additional Description:
Cagrilintide, an amylin analogue, is being investigated in combination with the GLP-1 receptor agonist semaglutide as a therapy to support sustained weight loss in overweight or obese individuals.
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment